A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)

Clinical trial NCT01390441 · TERMINATED

Trial details

NCT number: NCT01390441
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-07-01
Primary completion: 2014-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.